- Home
- GGT vs ALEC Comparison
GGT vs ALEC Comparison
Compare GGT & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GGT | ALEC |
|---|---|---|
| Founded | 1994 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 144.8M | 193.2M |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | GGT | ALEC |
|---|---|---|
| Price | $4.18 | $1.84 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $3.33 |
| AVG Volume (30 Days) | 59.7K | ★ 1.2M |
| Earning Date | 01-01-0001 | 02-25-2026 |
| Dividend Yield | ★ 15.56% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.83 | N/A |
| Revenue | N/A | ★ $69,048,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $6.90 | ★ N/A |
| Revenue Growth | N/A | ★ 12.26 |
| 52 Week Low | $4.32 | $0.87 |
| 52 Week High | $7.00 | $3.40 |
Technical Indicators
Market Signals| Indicator | GGT | ALEC |
|---|---|---|
| Relative Strength Index (RSI) | 51.63 | 66.56 |
| Support Level | $4.12 | $1.74 |
| Resistance Level | $4.25 | $1.94 |
| Average True Range (ATR) | 0.05 | 0.10 |
| MACD | -0.00 | 0.03 |
| Stochastic Oscillator | 68.37 | 83.84 |
Price Performance
Historical ComparisonAbout GGT Gabelli Multi-Media Trust Inc. (The)
Gabelli Multimedia Trust Inc is a non-diversified closed-end management investment company. Its investment objective is the long-term growth of capital with income as a secondary objective. The fund invests majority of its assets, under normal market conditions, in common stock and other securities, including convertible securities, preferred stock, options, and warrants of companies in the telecommunications, media, publishing, and entertainment industries.
About ALEC Alector Inc.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.